Sprycel and Valsartan drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Sprycel (dasatinib) and Valsartan (valsartan). Common drug interactions include scleroderma among females and pleural effusion among males.

The phase IV clinical study analyzes what interactions people have when they take Sprycel and Valsartan. It is created by eHealthMe based on reports of 58 people who take the same drugs from the FDA, and is updated regularly.

What is Sprycel?

Sprycel has active ingredients of dasatinib. It is often used in chronic myelogenous leukemia (cml). eHealthMe is studying from 29,788 Sprycel users. Check the latest studies of Sprycel.

What is Valsartan?

Valsartan has active ingredients of valsartan. It is often used in high blood pressure. eHealthMe is studying from 63,805 Valsartan users. Check the latest studies of Valsartan.



On Jul, 08, 2026

58 people who take Sprycel and Valsartan together, and have interactions are studied.

Sprycel and Valsartan drug interactions.

What are the common drug interactions of Sprycel and Valsartan, by gender? *:

female:

  1. Scleroderma (hard skin)
  2. Sepsis (a severe blood infection that can lead to organ failure and death)
  3. Anorectal disorder
  4. Ascites (accumulation of fluid in the abdominal cavity)
  5. Asthenia (weakness)
  6. Generalised oedema (swelling all over the body)
  7. Haemoglobin decreased
  8. Ovarian cancer (cancer of ovary)
  9. Rectal haemorrhage (bleeding from anus)
  10. Cardiac disorder

male:

  1. Pleural effusion (water on the lungs)
  2. Pruritus (severe itching of the skin)
  3. Dizziness
  4. Dyspnoea (difficult or laboured respiration)
  5. Eyelid oedema (eyelids are swollen and contain excessive fluid)
  6. Haematuria (presence of blood in urine)
  7. Haemorrhoids (a swollen vein or group of veins in the region of the anus)
  8. Lower gastrointestinal haemorrhage (bleeding in the large intestine, rectum, or anus is called lower gi bleeding)
  9. Melaena (the passage of black, tarry stools)
  10. Nausea (feeling of having an urge to vomit)

What are the common drug interactions of Sprycel and Valsartan, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Colitis (inflammation of colon)
  2. Diarrhoea

50-59:

  1. Cardiac arrest
  2. Drug ineffective
  3. Pleural effusion (water on the lungs)

60+:

  1. Pleural effusion (water on the lungs)
  2. Anaemia (lack of blood)
  3. Decreased appetite
  4. Headache (pain in head)
  5. Alanine aminotransferase increased
  6. Aspartate aminotransferase increased
  7. Pruritus (severe itching of the skin)
  8. Skin exfoliation (removal of the oldest dead skin cells)
  9. Neutrophil count decreased (less than normal number of neutrophil a type of blood cell)
  10. Blood creatinine increased

What are the existing conditions these people have? *

  1. Chronic Myeloid Leukaemia (long lasting type of cancer that starts in the blood-forming cells of the bone marrow and invades the blood): 38 people, 65.52%
  2. Acute Lymphocytic Leukemia (All) (cancer of the white blood cells characterized by excess lymphoblasts): 12 people, 20.69%
  3. Neuropathy Peripheral (surface nerve damage): 6 people, 10.34%
  4. Gastritis (inflammation of stomach): 6 people, 10.34%
  5. Constipation: 6 people, 10.34%
  6. Hyperlipidaemia (presence of excess lipids in the blood): 4 people, 6.90%
  7. Reflux Oesophagitis (an oesophageal mucosal injury that occurs of gastric contents into the oesophagus): 3 people, 5.17%
  8. Oesophagitis (inflammation of oesophagus): 3 people, 5.17%
  9. Itching: 3 people, 5.17%
  10. Genital Herpes (herpes infection of genital): 3 people, 5.17%

* Approximation only. Some reports may have incomplete information.

Do you take Sprycel and Valsartan?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Sprycel and Valsartan:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Sprycel:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Valsartan:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Sprycel and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Valsartan and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on dasatinib and valsartan (the active ingredients of Sprycel and Valsartan, respectively), and Sprycel and Valsartan (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: